It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

“[Wegovy] does three things,” Seltzer says ... Wegovy is FDA-approved for weight loss; the doses go up to 2.4mg. Ozempic is ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

LONDON, Nov 6 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab reported forecast-beating quarterly sales of its popular Wegovy weight-loss ... markets and volumes will go in that direction ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...